These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7713147

  • 1. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.
    Hirasawa Y, Nishio M, Maeda K, Yoshida K, Kita Y.
    Eur J Pharmacol; 1995 Jan 05; 272(1):39-43. PubMed ID: 7713147
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet activities of FK409, a new spontaneous NO releaser.
    Kita Y, Hirasawa Y, Yoshida K, Maeda K.
    Br J Pharmacol; 1994 Oct 05; 113(2):385-8. PubMed ID: 7834188
    [Abstract] [Full Text] [Related]

  • 3. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409.
    Hirasawa Y, Kato Y, Fukuyama S, Ohno M, Nishino S, Kato M, Kita Y.
    Thromb Haemost; 1998 Mar 05; 79(3):620-4. PubMed ID: 9531052
    [Abstract] [Full Text] [Related]

  • 4. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
    Umetsu T, Murata T, Nishio S.
    Arzneimittelforschung; 1989 Jan 05; 39(1):68-73. PubMed ID: 2541730
    [Abstract] [Full Text] [Related]

  • 5. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
    Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T.
    Arzneimittelforschung; 1985 Jan 05; 35(12):1816-8. PubMed ID: 3913423
    [Abstract] [Full Text] [Related]

  • 6. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
    Kajikawa N, Nogimori K, Murata T, Nishio S, Uchiyama S.
    Arzneimittelforschung; 1989 Apr 05; 39(4):495-9. PubMed ID: 2665758
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.
    Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K.
    Eur J Pharmacol; 1994 May 12; 257(1-2):123-30. PubMed ID: 8082692
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.
    Fukuyama S, Hirasawa Y, Kato Y, Nishio M, Ohno M, Nishino S, Maeda K, Kato M, Kita Y.
    J Pharmacol Exp Ther; 1997 Jul 12; 282(1):236-42. PubMed ID: 9223559
    [Abstract] [Full Text] [Related]

  • 9. Antianginal effects of FK409, a new spontaneous NO releaser.
    Kita Y, Ozaki R, Sakai S, Sugimoto T, Hirasawa Y, Ohtsuka M, Senoh H, Yoshida K, Maeda K.
    Br J Pharmacol; 1994 Dec 12; 113(4):1137-40. PubMed ID: 7889266
    [Abstract] [Full Text] [Related]

  • 10. [Cardiovascular effects of beraprost sodium (TRK-100), a prostacyclin analogue in the dog].
    Nishio S, Matsuura H, Hattori M, Endoh T, Yamada N, Hirano T, Murai T, Miyao Y, Kanai T, Umetsu T.
    Nihon Yakurigaku Zasshi; 1989 Dec 12; 94(6):351-61. PubMed ID: 2514128
    [Abstract] [Full Text] [Related]

  • 11. FR144420, a novel, slow, nitric oxide-releasing agent.
    Kita Y, Ohkubo K, Hirasawa Y, Katayama Y, Ohno M, Nishino S, Kato M, Yoshida K.
    Eur J Pharmacol; 1995 Mar 06; 275(2):125-30. PubMed ID: 7796846
    [Abstract] [Full Text] [Related]

  • 12. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
    Kita Y, Hirasawa Y, Fukuyama S, Ohkubo K, Kato Y, Takamatsu H, Ohno M, Nishino S, Kato M, Seki J.
    J Pharmacol Exp Ther; 1996 Feb 06; 276(2):421-5. PubMed ID: 8632305
    [Abstract] [Full Text] [Related]

  • 13. Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds.
    Fukuyama S, Hirasawa Y, Cox D, Koda S, Kita Y.
    Pharm Res; 1995 Dec 06; 12(12):1948-52. PubMed ID: 8786971
    [Abstract] [Full Text] [Related]

  • 14. Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits.
    Murai T, Muraoka K, Saga K, Sakai A, Sato N, Amemiya K, Yajima M, Murata T, Umetsu T, Nishio S.
    Arzneimittelforschung; 1989 Aug 06; 39(8):856-9. PubMed ID: 2510741
    [Abstract] [Full Text] [Related]

  • 15. Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.
    Hirasawa Y, Sugimoto T, Fukuyama S, Kato Y, Takamatu H, Ohno M, Nishino S, Kato M, Maeda K, Seki J, Kita Y.
    Eur J Pharmacol; 1996 May 06; 303(1-2):55-9. PubMed ID: 8804911
    [Abstract] [Full Text] [Related]

  • 16. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.
    Nishio S, Matsuura H, Kanai N, Fukatsu Y, Hirano T, Nishikawa N, Kameoka K, Umetsu T.
    Jpn J Pharmacol; 1988 May 06; 47(1):1-10. PubMed ID: 2842529
    [Abstract] [Full Text] [Related]

  • 17. Effect of TRK-100, a stable orally active prostacyclin analogue, on platelet function and plaque size in atherothrombotic strokes.
    Isaka Y, Handa N, Imaizumi M, Kimura K, Kamada T.
    Thromb Haemost; 1991 Apr 08; 65(4):344-50. PubMed ID: 2057914
    [Abstract] [Full Text] [Related]

  • 18. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H.
    Arzneimittelforschung; 1989 Aug 08; 39(8):867-76. PubMed ID: 2510743
    [Abstract] [Full Text] [Related]

  • 19. Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level.
    Kita Y, Sugimoto T, Hirasawa Y, Yoshida K, Maeda K.
    Br J Pharmacol; 1994 Sep 08; 113(1):5-6. PubMed ID: 7812632
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats.
    Matsumura Y, Nishiura M, Deguchi S, Hashimoto N, Ogawa T, Seo R.
    J Pharmacol Exp Ther; 1998 Dec 08; 287(3):1084-91. PubMed ID: 9864296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.